Sustained Analgesic Effect of the Rho Kinase Inhibitor AS1892802 in Rat Models of Chronic Pain
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-09-20
著者
-
Takeshita Nobuaki
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Yoshimi Eiji
Pharmacology Research Laboratories, Astellas Pharma, Inc., Japan
-
Shimizu Yasuaki
Pharmacology Research Laboratories, Astellas Pharma, Inc., Japan
-
Yamamoto Hiroko
Pharmacological Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Furuichi Yasuhisa
Applied Pharmacology Research Laboratories Astellas Phahrma Inc.
-
Yoshimi Eiji
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Shimizu Yasuaki
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Yamamoto Hiroko
Pharmacology Research Laboratories Astellas Phahrma Inc.
関連論文
- A NOVEL INHIBITOR OF VACUOLAR ATPase, FR202126, PREVENTS ALVEOLAR BONE DESTRUCTION IN EXPERIMENTAL PERIODONTITIS IN RATS
- Alleviating Effects of AS1892802, a Rho Kinase Inhibitor, on Osteoarthritic Disorders in Rodents
- FR149175, a β_3-Adrenoceptor-Selective Agonist, Is a Possible Therapeutic Agent for Non-Insulin-Dependent Diabetes Mellitus
- Sustained Analgesic Effect of the Rho Kinase Inhibitor AS1892802 in Rat Models of Chronic Pain
- Sustained Analgesic Effect of the Rho Kinase Inhibitor AS1892802 in Rat Models of Chronic Pain
- Alleviating Effects of AS1892802, a Rho Kinase Inhibitor, on Osteoarthritic Disorders in Rodents